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Problem Definition
Adrenal insufficiency after transsphenoidal 
resection of pituitary adenoma (PA) can be 
seen in 1-12% of cases. In PA, the use of 
postoperative cortisol measurement and 
supplementation remains controversial. It is 
unclear whether postoperative cortisol 
supplementation has a measurable effect on 
improving outcomes in patients with 
pituitary adenoma undergoing endoscopic 
transsphenoidal surgery (ETS). The 
objective of the study was to evaluate a 
postoperative steroid treatment protocol in 
patients with PA undergoing ETS.
Aims For Improvement
S: develop a steroid sparing protocol for 
PA patients undergoing ETS.
M: measure steroid administration and 
levels, as well as outcomes.
A: achievable because involves small 
protocol modification.
R: relevant because this can spare 
unnecessary medication.
T: test over the period of multiple years.
Intervention
A retrospective cohort study was 
performed for patients undergoing ETS 
from 2005 to 2020 for PA at a single 
tertiary academic center. Patients were 
divided into two groups: those managed 
by a routine postoperative glucocorticoid 
supplementation protocol (standard 
protocol) and those that received 
supplementation based on postoperative 
cortisol laboratory assessment (sparing 
protocol). Management was otherwise the 
same between groups. Both univariate 
and multivariate analysis was performed.
Measurements/ Results
Among 535 patients, 21% (n=111) 
received postoperative steroids, while the 
remainder (n=424) did not. There were 
no differences in mean length of stay (3 
days vs. 3 days, p=0.72), sinonasal
complaints (27% vs. 19%, p=0.12), 30-day 
readmission (5% vs. 5%, p=0.44), and 
perioperative complications (5% vs. 5%, 
p=0.79) between both the groups. A 
multivariate model also supported that 
both groups were comparable in 
predicting length of stay, 30-day 
readmission, and complications.
Lessons Learned
In patients who underwent endoscopic 
transsphenoidal surgery for pituitary 
adenoma, there were no differences in 
outcomes between those on the standard 
postoperative steroids protocol and those 
on the postoperative steroid sparing 
protocol. This suggests that the routine 
administration of glucocorticoids may not 
be necessary following surgery for pituitary 
adenoma.
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Length of Stay, mean 
days (sd)
3 (2) 3 (2) 0.72
30-day Readmission, n 
(%)
6 (5%) 21 (5%) 0.44
Headache, n 0 7
CSF leak, n 2 4
Hyponatremia, n 1 5
Adrenal insufficiency, n 0 3
Other*, n 3 2
Postoperative sinonasal 
complaints, n (%)
21 (19%) 125 (27%) 0.12
Septal perforation, n 2 9
Sinusitis, n 16 70
Synechiae, n 3 37
Postoperative SNOT 
score, mean (SD)
22 (24) 16 (16) 0.12
Perioperative 
Complications, n (%)
6 (5%) 20 (5%) 0.79
Epistaxis, n 2 5
Meningitis, n 0 0
Pulmonary embolism, n 2 3
Sellar hemorrhage, n 2 2
Thromboembolism, n 0 10
